Hematology Oncology Consultants PC-Troy

Summary

Hematology Oncology Consultants PC-Troy is a medical facility located in Troy, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Colorectal Cancer, Chronic Lymphocytic Leukemia and other specialties. Hematology Oncology Consultants PC-Troy is involved with conducting 50 clinical trials across 104 conditions. There are 8 research doctors associated with this hospital, such as Dana Zakalik, Andrew A. Muskovitz, Faisal Musa, and Joseph M. Anderson.

Top PIs

Clinical Trials running at Hematology Oncology Consultants PC-Troy

Lung Cancer

Breast Cancer

Esophageal cancer

Breast cancer

Ovarian Cancer

Bladder Cancer

Stomach Cancer

Prostate Cancer

Colorectal Cancer

Gastric cancer

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria